Company / Return on Equity (ROE)
iBio, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-167.4%
FY2025
5-year range
-422.7% / -15.1%
FY2021-FY2025
Trend
+60.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
iBio, Inc. reports negative total equity of -167.4% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-167.4% in FY2025 with a 5-year CAGR of -136.3%.
Improved from -327.1% to -167.4% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -130.8pp
- 5-Year Change
- -136.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 60.4% year-over-year.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -167.4% | +60.4% |
| FY2024 | -422.7% | -29.2% |
| FY2023 | -327.1% | -794.6% |
| FY2022 | -36.6% | -141.5% |
| FY2021 | -15.1% | +51.3% |
| FY2020 | -31.1% | +95.2% |
| FY2019 | -653.9% | -627.4% |
| FY2018 | -89.9% | +17.9% |
| FY2017 | -109.5% | -64.3% |
| FY2016 | -66.7% | -104.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026